These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. rs56405341 Variant Associates with Expression of C4orf33 and C4orf33 Was Downregulated in Alzheimer's Disease and Progressive Supranuclear Palsy. Zhang Y; Xue Y; Wang L; Han Z; Wang T; Zhang H; Liu G; Xiao X J Alzheimers Dis; 2023; 96(1):57-64. PubMed ID: 37742642 [TBL] [Abstract][Full Text] [Related]
15. Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome. Tsuboi Y; Josephs KA; Boeve BF; Litvan I; Caselli RJ; Caviness JN; Uitti RJ; Bott AD; Dickson DW Mov Disord; 2005 Aug; 20(8):982-8. PubMed ID: 15834857 [TBL] [Abstract][Full Text] [Related]
16. Tau and saitohin gene expression pattern in progressive supranuclear palsy. Ezquerra M; Gaig C; Ascaso C; Muñoz E; Tolosa E Brain Res; 2007 May; 1145():168-76. PubMed ID: 17320831 [TBL] [Abstract][Full Text] [Related]
17. Different immunoreactivities of the microtubule-binding region of tau and its molecular basis in brains from patients with Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Arai T; Ikeda K; Akiyama H; Tsuchiya K; Iritani S; Ishiguro K; Yagishita S; Oda T; Odawara T; Iseki E Acta Neuropathol; 2003 May; 105(5):489-98. PubMed ID: 12677450 [TBL] [Abstract][Full Text] [Related]
18. Distinct phosphorylation profiles of tau in brains of patients with different tauopathies. Samimi N; Sharma G; Kimura T; Matsubara T; Huo A; Chiba K; Saito Y; Murayama S; Akatsu H; Hashizume Y; Hasegawa M; Farjam M; Shahpasand K; Ando K; Hisanaga SI Neurobiol Aging; 2021 Dec; 108():72-79. PubMed ID: 34536819 [TBL] [Abstract][Full Text] [Related]